about
The benefits and risks of testosterone replacement therapy: a reviewDifferential alterations in gene expression profiles contribute to time-dependent effects of nandrolone to prevent denervation atrophy.Diagnosis and treatment of sexual dysfunctions in late-onset hypogonadismHypogonadism in the aging male diagnosis, potential benefits, and risks of testosterone replacement therapy.Androgens and male aging: Current evidence of safety and efficacy.Genetic variation in androgen disposition: implications in clinical medicine including testosterone abuse.Effect of Testosterone Replacement Therapy on Cognitive Performance and Depression in Men with Testosterone Deficiency Syndrome.How to help the aging male? Current approaches to hypogonadism in primary care.Phytoandrogenic properties of Eurycoma longifolia as natural alternative to testosterone replacement therapy.To treat or not to treat with testosterone replacement therapy: a contemporary review of management of late-onset hypogonadism and critical issues related to prostate cancer.Effects of testosterone replacement therapy on hypogonadal men with osteopenia or osteoporosis: a subanalysis of a prospective randomized controlled study in Japan (EARTH study).Clinical efficacy of Japanese traditional herbal medicine (Kampo) in patients with late-onset hypogonadism.Are urge incontinence and aging risk factors of erectile dysfunction in patients with male lower urinary tract symptoms?Testosterone replacement therapy by testosterone ointment relieves lower urinary tract symptoms in late onset hypogonadism patients.Short term testosterone replacement therapy improves libido and body composition.Lower urinary tract symptoms after hormone replacement therapy in Japanese patients with late-onset hypogonadism: a preliminary report.The effect of testosterone therapy on lower urinary tract symptoms/bladder and sexual functions in men with symptomatic late-onset hypogonadism.Symptoms of testosterone deficiency in early middle aged men.Change in testosterone concentrations over time is a better predictor than the actual concentrations for symptoms of late onset hypogonadism.Anabolic deficiencies in men with systolic heart failure: do co-morbidities and therapies really contribute significantly?The high prevalence of testosterone deficiency in population of Polish men over 65 years with erectile dysfunctions.Differentiation of umbilical cord mesenchymal stem cells into steroidogenic cells in comparison to bone marrow mesenchymal stem cells.Should frailty be treated with testosterone?
P2860
Q24658011-13B9F0BB-DA4D-4DF9-AFCA-A8B95E4758A9Q33726235-EB688F72-DB0B-444E-9E75-4291862460CDQ35624509-D8A94611-7FE4-45A5-8230-07788E1B2FA9Q35852422-4A31316D-2FFE-4230-800F-0ED1AAD91A96Q37084126-4E8240BC-14E7-4EA6-B2C4-B1418D23DD53Q37481427-CBBF41C1-5914-4DFF-9FF9-A28D46E7BDB7Q37553938-4FC4AC47-A16D-44A5-B9FD-3A2C36216198Q38052169-63E70EF4-9259-4EAF-9F5E-5F09A6012D22Q38175427-CE435B60-BFC0-4542-9D17-8764F5C6009EQ38212063-EA1890DD-F394-45B9-B972-400FBB6D39D1Q38873488-5CE2BB55-DE4F-4F4E-8F81-F0198FD5D600Q39291240-E17450F2-3694-47C9-B387-EB64417C8328Q40341847-859E365C-6359-423F-97E9-1C1C0BF6E8C1Q42925108-6AE0EACF-3F55-4DCF-AB52-CBF8E957ECF4Q43176620-42583AE9-A7BC-4A37-A127-BECB7D6EBA3FQ46116814-C354377C-1575-49B5-8505-CD2A09BC23B6Q46343590-81AD3A10-0D79-4742-80E5-FA06F076E9D0Q47974097-FF9310D0-9CE5-49C7-99F2-F0C343B7CB92Q50788918-9D72063D-D02D-4798-8AC1-31E22CD0F11AQ50876472-2858F90A-01BE-43FE-AFE5-CA3C35FAF45EQ51349912-DF9A1187-61C4-4EF8-A2F4-CA292D1EB576Q51816143-9660FBE0-2B6B-4BC5-A277-4A429F8025F2Q53067261-910D083F-45B2-408D-B4B0-18F14326C39B
P2860
description
im Januar 2007 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в січні 2007
@uk
name
Testosterone therapy in the aging male
@en
Testosterone therapy in the aging male
@nl
type
label
Testosterone therapy in the aging male
@en
Testosterone therapy in the aging male
@nl
prefLabel
Testosterone therapy in the aging male
@en
Testosterone therapy in the aging male
@nl
P2093
P2860
P1433
P1476
Testosterone therapy in the aging male
@en
P2093
Bruno Lunenfeld
Eberhard Nieschlag
P2860
P304
P356
10.1080/13685530701485998
P577
2007-01-01T00:00:00Z